Cite
HARVARD Citation
d'Hautefeuille, C. et al. (n.d.). ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. Leukemia research. pp. S68-S69. [Online].